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nd drug resistance. Our aim was to characterize by full
equence BCG Mexico 1931 for using in the new develop
accine.
Methods: The sequence of BCG Mexico 1931 was per-
ormed with 2X pyrosequencing method. BCG Mexico 1931
enetic proﬁle was performed by multiplex PCR and PFGE.
he multiplex PCR was performed to detect RD and DU
egions in strains. The reference BCG strains used in this
tudy were Pasteur 1173P2, Phipps, Tice and Danish 1331.
Results: The circular chromosome at 99.8% coverage of
CG Mexico 1931 was 4 350 386-bp, its analyses conﬁrm the
D1, RD2, nRD18 absence and the presence of duplication
U2 group IV described by multiplex PCR. The comparison of
CG Pasteur1173P2 genome sequence with BCG Mexico 1931
howed differences between strains, including the presence
f RD14, SNPs and the absence of DU1. In addition, three
ew RD regions of 53, 655 and 2847 bp were uncovered. The
omparison of proﬁles obtained by PCR multiplex showed
hat BCG Mexico 1931 proﬁle was identical to BCG Phipps
nd Tice, with the lost of RD1, RD2, nRD18 and presence of
U2 group IV. PFGE was performed with AsnI/DraI enzymes,
he analyses detected 18/12 fragments in BCG Danish 1331
nd Mexico 1931, 17/12 in Pasteur 1173P2, 15/10 in Phipps
nd 14/10 in Tice, respectively. Interesting, the restriction
attern with AsnI showed the presence of 220 kb fragment
nly in BCG Mexico, Tice and Phipps.
Conclusion: The BCG Mexico 1931 showed a close rela-
ion with BCG Phipps and Tice, strains situated into group IV
rom genealogy of BCG vaccines. However, in diverse studies
hese strains shown differences on the induction of immune
esponse.
oi:10.1016/j.ijid.2010.02.630
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neumococcal vaccination - is hyporesponsiveness a prob-
em?
. Lode
RCMS, Berlin, Germany
Background: Several studues in the past have
emostrated that the pneumococcal polysaccharide
accine (PPV 23) will induce hyporesponsiveness in vacci-
ated patients over a long time period. The duration of
his effect and the impactv on a second vaccination with
conjugated vaccine (PCV 13) after at least 3 years is not
nown.
Methods: To address these open questions we investi-
ated 55 persons (30 males, age between 68 and 87 years),
ho had a ﬁrst PPV 23 - vaccination 3 - 8 years before
nd received a second vaccination with PCV 13. Immedi-
tely before and 4 - 6 weeks after PCV 13 vaccination
lood specimen were taken and antibodies to 13 individ-
al poysaccharides (1,3,4,5,6A,6B,7F,9 V,14,18,19A,19F,25F)
ere determined by a validated enzyme-linked immunosor-
ent assay.
Results: 3 - 8 years after PPV 23 vaccination antibody
oncentrations were low but in 11 out of 13 serotypes still
bove 1,0 !g/ml (the assumed protection level for adults);
nly serotypes 3 and 23F had mean concentrations (+/- SD)
f 0,66+/- 0,38 !g/ml and 0,57+/- 0.39 !g/ml. 4 - 6 weeks
h
t
T
iternational Congress on Infectious Diseases (ICID) Abstracts
fter vaccination with PCV 13 all serotypes showed an signif-
cant increase in antibody concentrations; however, a great
esponse variability between the different serotypes was
easured with small antibody increases in serotype 3 and
igh concentrations in serotypes 4, 5,7F,19A and 19F.The
olerance of vaccination with PCV 13 was excellent.
Conclusion: The results of this study demonstrate that
ﬁrst PPV 23 vaccination has only limited impact on a
econd vaccination with a new conjugated pneumococcal
accine(PVP13) 3 - 8 years later. Hyporesponsiveness was
ot a major problem in this study. However, these results
ave to be conﬁrmed in a study with a greater number of
lderly patients.
oi:10.1016/j.ijid.2010.02.631
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ntravenous immunoglobulin manufactured from selected
hinese donors protects mice from lethal Enterovirus 71
nfection
. Cao, J. Han, E. Qin, C. Qin ∗
Beijing Institute of Microbiology and Epidemiology, Beijing,
hina
Background: Enterovirus 71 (EV71) has emerged as a
igniﬁcant cause of acute encephalitis and paralysis in
hina, resulting in hundreds of deaths in young children
ince 2006. Passive transfer of intravenous immunoglobu-
in (IVIG) from Chinese donors has been associated with
educed mortality in children with severe EV71 infec-
ions. The anti-EV71 neutralization antibodies in Chinese
VIG products may contribute to the protection from EV71
nfection.
Methods: A modiﬁed high-throughput microneutraliza-
ion assay was performed to screen for plasma units
ontaining high titer (>100) anti-EV71 antibodies from Chi-
ese plasma donors. Positive units were then pooled and
rocessed into pharmaceutical grade EV71-speciﬁc IVIG
EV71-IVIG). Different doses (0.1 to 5mg) of EV71-IVIG and
ommercial IVIG were administered following lethal EV71
nfection in sucking mice, respectively, according to the spe-
iﬁc experimental protocol. Mice were monitored daily for
ody weight and mortality.
Results: About 10% of the plasma units from Chinese
lasma donors were selected to produce EV71-IVIG. In vitro
eutralization assays showed that the anti-EV71 antibod-
es titer (>1024) in EV71-IVIG preparations was 10-fold
igher than that in commercial IVIG preparations. Full
rotection was archived when the infected mice were
reated with EV71-IVIG, while similar treatments using com-
ercial IVIG had no protective effect. Recovery of the
nfected mice was dependent on the dose and time of IVIG
dministration.Conclusion: These results demonstrated that IVIG with
igher titer (>1024) neutralization antibodies conferred pro-
ection against lethal EV71 challenge in an animal model.
his ﬁnding also suggested that blood from selected donors
n EV71 endemic regions can improve the potency of IVIG and
